Keyphrases
Gene Therapy
100%
Photosystem II
48%
Adeno-associated Viral
48%
Insulin Resistance
48%
Lysosomal Storage Disease
36%
Obesity
34%
Cancer Patients
30%
Adeno-associated Viral Vector
24%
P-EGFR
24%
HPV16 E5
24%
Hunter Syndrome
24%
Skeletal Alterations
24%
Neurologic
24%
Surgeons
24%
21-gene
24%
Head-and-neck Cancer
24%
AAV Gene Therapy
24%
COVID-19 Pandemic
24%
Mucopolysaccharidosis IVA
24%
Bone Morphogenetic protein-7 (BMP-7)
24%
Mouse Model
24%
Obesity Resistance
24%
Health Systems
24%
Fibroblast Growth Factor 21 (FGF21)
24%
Prognostic Biomarker
24%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
24%
Epidermal Growth Factor Receptor
24%
EGFR Phosphorylation
19%
Type 2 Diabetes Mellitus (T2DM)
17%
HPV16
16%
Iduronate-2-sulfatase
16%
Neuroinflammation
16%
Serotype 9
14%
CNS Tissue
12%
Head-and-neck
12%
Enzyme Replacement Therapy
12%
Energy Expenditure
10%
Peripheral Tissues
10%
Cerebrospinal Fluid
10%
Therapeutic Potential
10%
Heparan Sulfate
10%
HPV Negative
9%
Clinical Translation
8%
Keratan Sulfate
7%
AAV9
7%
GALNS
7%
Liver
7%
Vector Encoding
7%
Negative Samples
7%
Brown Adipose Tissue
6%
Medicine and Dentistry
Gene Therapy
96%
Mucopolysaccharidosis
48%
Diseases
37%
Lysosomal Storage Disease
34%
Somatics
30%
Hunter Syndrome
24%
Human Papillomavirus Type 16
24%
Epidermal Growth Factor Receptor
24%
Biological Marker
24%
Insulin Resistance
24%
Bone Morphogenetic Protein
24%
Head and Neck Cancer
24%
Adeno-Associated Virus
24%
Surgeon
24%
COVID-19
24%
Oropharynx Carcinoma
24%
Storage Disease
22%
Adeno Associated Virus Vector
20%
Neuroinflammation
15%
Serotype
14%
Lifespan
12%
Sanfilippo Syndrome
12%
Iduronate 2 Sulfatase
12%
Neck
12%
Energy Expenditure
10%
White Adipose Tissue
10%
Enzyme Replacement Therapy
10%
Cerebrospinal Fluid
9%
Keratan Sulfate
7%
Maturity Onset Diabetes of the Young
6%
Genetic Disorder
6%
Exploratory Behavior
6%
Locomotion
6%
Homeostasis
6%
N Acetylglucosamine 6 Sulfatase
6%
Scope of Practice
6%
Body Fluid
6%
Otorhinolaryngology
6%
Infection
6%
Cross Sectional Study
6%
Patient Care
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Oncology
6%
Neck Cancer Surgery
6%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Resistance
48%
Mucopolysaccharidosis
24%
Biological Marker
24%
Bone Morphogenetic Protein
24%
Human Papillomavirus Type 16
24%
Fibroblast Growth Factor 21
24%
Oropharynx Cancer
24%
Hunter Syndrome
24%
Oropharynx Carcinoma
24%
Epidermal Growth Factor Receptor
24%
Non Insulin Dependent Diabetes Mellitus
20%
Adeno Associated Virus Vector
17%
Disease
13%
Iduronate 2 Sulfatase
12%
Replacement Therapy
10%
Lysosome Storage Disease
10%
Keratan Sulfate
7%
Inflammation
6%
Ob/Ob Mouse
6%
Fatty Liver
6%